Conformity with guideline-directed medical therapy and clinical outcomes in secondary cardiovascular prevention—results of a German claims data analysis - Scorecard - MDSpire
Advertisement
Conformity with guideline-directed medical therapy and clinical outcomes in secondary cardiovascular prevention—results of a German claims data analysis
Clinical Scorecard: Adherence to Guideline-Recommended Medical Therapy and Its Impact on Clinical Outcomes in Secondary Cardiovascular Prevention: Insights from a German Claims Data Study
At a Glance
Category
Detail
Condition
Secondary cardiovascular prevention after myocardial infarction, stroke, or transient ischemic attack
Key Mechanisms
Guideline-recommended medical therapy (GDMT) includes acetylsalicylic acid (ASA), lipid-lowering treatment (LLT), angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB), and calcium channel blockers (CCB) or diuretics.
Target Population
Patients with a history of myocardial infarction, stroke, or transient ischemic attack.
Care Setting
Outpatient and inpatient settings in Germany.
Key Highlights
CV diseases are the leading cause of mortality in Europe.
Patients post-MI or stroke/TIA are at high risk for recurrent CV events.
Guidelines recommend specific combinations of medications for secondary prevention.
There is a noted lack of adherence to guideline-recommended therapies.
The study assesses the impact of GDMT on clinical outcomes.
Guideline-Based Recommendations
Diagnosis
Use ICD-10-GM codes for identifying myocardial infarction (I21), ischemic stroke (I63), and transient ischemic attack (G45.8/0.9).
Management
Implement GDMT including ASA, LLT, and ACEi/ARB for MI; ASA/OAC, LLT, ACEi/ARB, and CCB/diuretics for stroke/TIA.
Monitoring & Follow-up
Monitor adherence to GDMT and clinical outcomes for 12 months post-index event.
Risks
Patients not adhering to GDMT are at increased risk for recurrent cardiovascular events.
Patient & Prescribing Data
Patients insured by AOK PLUS with a history of MI, stroke, or TIA.
GDMT is defined as a combination of specific medications prescribed within defined timeframes post-event.
Clinical Best Practices
Ensure adherence to guideline-recommended therapies for secondary prevention.
Utilize claims data for real-world treatment analysis and health-economic evaluations.
Conduct regular follow-ups to monitor medication adherence and clinical outcomes.
Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients
